Financial Performance - The company's operating revenue for Q1 2023 reached ¥101,965,867.56, representing a year-on-year increase of 217.09%[5] - Net profit attributable to shareholders was ¥14,150,249.80, marking a significant increase of 269.25% compared to the same period last year[5] - Basic earnings per share (EPS) stood at ¥0.0354, reflecting a growth of 269.38% year-on-year[6] - The company's net profit for Q1 2023 was not explicitly stated, but the significant increase in revenue suggests a positive trend in profitability[17] - The net profit for Q1 2023 was CNY 14,150,249.80, compared to a net loss of CNY 8,360,376.19 in Q1 2022, representing a significant turnaround[18] - Operating profit for Q1 2023 was CNY 15,749,691.13, an increase from a loss of CNY 9,269,724.96 in the same period last year[18] - The company achieved a gross profit margin of approximately 58.1% in Q1 2023, compared to 62.9% in Q1 2022[26] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥44,752,786.86, but improved by 12.48% compared to the previous year[6] - Cash flow from operating activities for Q1 2023 was negative at CNY -44,752,786.86, an improvement from CNY -51,137,101.07 in Q1 2022[20] - The cash flow from operating activities showed a net outflow of ¥45,872,472.04, an improvement from the outflow of ¥54,840,285.25 in Q1 2022[29] - Cash and cash equivalents as of March 31, 2023, amounted to RMB 330,819,976.84, up from RMB 153,581,546.70 at the end of 2022, reflecting a growth of approximately 115.5%[14] - The company reported cash inflow from investment activities of CNY 222,882,193.00 in Q1 2023, a significant recovery from a cash outflow of CNY -36,909,166.73 in the previous year[21] - The company reported a cash and cash equivalents balance of ¥313,466,953.47 at the end of Q1 2023, compared to ¥388,069,421.53 at the end of Q1 2022[30] Research and Development - Research and development (R&D) expenses totaled ¥30,764,318.46, which accounted for 30.17% of operating revenue, a decrease of 67.42 percentage points from the previous year[6] - Research and development expenses for Q1 2023 were RMB 24,876,396.77, slightly down from RMB 26,826,714.21 in Q1 2022, a decrease of about 7.3%[17] - Research and development expenses for Q1 2023 were ¥23,627,576.72, slightly down from ¥25,118,218.50 in Q1 2022[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,653,545,275.83, down 1.99% from the end of the previous year[6] - Total assets as of March 31, 2023, were RMB 1,653,545,275.83, down from RMB 1,687,169,158.93 at the end of 2022, a decrease of approximately 2.0%[15] - Total liabilities decreased to RMB 341,762,946.19 from RMB 390,385,872.89, indicating a reduction of about 12.4%[16] - The total liabilities decreased from ¥386,085,671.10 in the previous year to ¥337,567,642.22 in Q1 2023, reflecting a reduction of approximately 12.6%[24] - The total owner's equity increased to ¥1,323,373,035.16 in Q1 2023 from ¥1,305,653,318.61 in Q1 2022, marking a growth of about 1.4%[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,645[11] - The largest shareholder, Shandong Shanda Capital Operation Co., Ltd., held 29.58% of the shares, totaling 118,342,400 shares[11] Non-Recurring Gains - The company reported non-recurring gains of ¥2,031,029.24 for the period, primarily from government subsidies and other non-operating income[8]
山大地纬(688579) - 2023 Q1 - 季度财报